share_log

百濟神州:內幕消息 - 百濟神州替雷利珠單抗獲美國食品藥品監督管理局(FDA)批准,用於治療既往接受化療後晚期或轉移性食管鱗狀細胞癌患者

BEIGENE: INSIDE INFORMATION - BEIGENE RECEIVES FDA APPROVAL FOR TEVIMBRA (TISLELIZUMAB) FOR THE TREATMENT OF ADVANCED OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA AFTER PRIOR CHEMOTHERAPY

香港交易所 ·  Mar 14 20:26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more